Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services National Institutes of Health
 AGENCY: National Institutes of Health, HHS.
 ACTION: Notice.
 SUMMARY: In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institutes of Health (NIH), Clinical Center (CC) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
 DATES: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication.
 FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Ms. Mikia P. Currie, Office of Policy for Extramural Research Administration, 6705 Rockledge Drive, Suite 350, Bethesda, Maryland 20892, or call a non-toll free number (301) 435-0941 or Email your request, including your address to: 
                        *ProjectClearanceBranch@mail.nih.gov.*
                         Formal requests for additional plans and instruments must be requested in writing.


SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires: written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. *Proposed Collection Title:*
                     Federal COVID Response—Audience Feedback to Inform Ongoing Messaging and Strategies for “Combat COVID,” OMB #0925-0769, exp.12/31/2021, EXTENSION, National Institutes of Health (NIH). *Need and Use of Information Collection:*
                     The purpose of the information collection is to collect routine feedback from the Combat COVID Initiative's two target audiences (the general public and healthcare providers) to identify evolving needs and better disseminate relevant information as it relates to COVID-19 treatment and ACTIV clinical trial resources, specifically. Data collected will be used to inform the development and broad dissemination of Combat COVID resources, including new or enhanced message and material concepts (
                    *e.g.,*
                     social media ads, digital display ads, out-of-home ads), and/or web pages (
                    *combatcovid.hhs.gov*). Because the COVID-19 treatment landscape continues to evolve, new evidence-based information continues to come to the forefront, and audience needs continue to change, it is critical for the Federal COVID Response (FCR) Team to collect quick audience feedback from the general public (especially from groups who have not historically been well-represented in clinical trials) and healthcare providers to identify these evolving needs. By understanding target audience needs, the FCR team will be able to properly develop and broadly disseminate relevant COVID-19 treatment and ACTIV clinical trial resources. OMB approval is requested for 1 year. There are no costs to respondents other than their time. The total estimated annualized burden hours are 3,528. Estimated Annualized Burden Hours
Type of respondent
Number of
                             respondents
Number of
                             responses per 
                             respondent
Average time
                             per response 
                             (in hours)
Total annual
                             burden hoursConsumer Audience Feedback Team Screener
120
1
5/60
10HCP Audience Feedback Team Screener
40
1
5/60
3( print page 50144)Consumer Audience Feedback Activity
60
8
1
480HCP Audience Feedback Activity
20
8
1
160Benchmark & Follow-Up Web Surveys—Consumer Audience
2,000
5
15/60
2,500Benchmark & Follow-Up Web Survey—HCP Audience
300
5
15/60
375Total
2,540
12,300

3,528
 Dated: September 1, 2021. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health.


[FR Doc. 2021-19383 Filed 9-3-21; 8:45 am] BILLING CODE 4140-01-P